GlassScriptPhysician profile
Lauryn Currens
NPI 1780144360
$16,956.11
in general payments reported to CMS, 2019-2025
8 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15K · 2024: $46.48 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Consulting Fee: $1,225 · Food and Beverage: $711 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Consulting Fee | $1,225.00 |
| Food and Beverage | $711.11 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,000.00 | 2023 | Activa PC |
| Amneal Pharmaceuticals LLC | $1,287.13 | 2025 | Crexont |
| Acadia Pharmaceuticals INC | $278.53 | 2023-2024 | Nuplazid |
| Abbvie INC. | $196.29 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $117.65 | 2025 | |
| Lundbeck LLC | $32.06 | 2025 | Vyepti |
| Genzyme Corporation | $24.45 | 2025 | |
| Merz Pharmaceuticals, LLC | $20.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauryn Currens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.